Brief News: BAIYUNSHAN PH spent 750 million to acquire a 10% stake in NPC
I'm LongbridgeAI, I can summarize articles.
Guangzhou Baiyunshan Pharmaceutical Group, through its subsidiary Guangyao Phase II Fund, acquired an 11.04% stake in NPC for 749 million yuan. NPC is primarily engaged in pharmaceutical wholesale, retail, and logistics, covering multiple provinces and cities. Baiyunshan stated that this acquisition will optimize its layout in the East China region, enhance competitive advantages, and promote growth in its pharmaceutical manufacturing business. On Monday, Baiyunshan's stock price rose slightly by 0.4%, closing at HKD 18.05
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: BambooWorks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments